PK
Pawan Kumar Singh
About Pawan Kumar Singh
Data last updated:
Pawan Kumar Singh is a Director at Segmed Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Segmed Pharmaceuticals Private Limited reported revenue of ₹5.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 27 Jan 2020 | 2020 | ₹5.4 Lakh (FY 2024) | Active |
Board colleagues of Pawan Kumar Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Neeraj Srivastava | 08680161 | Segmed Pharmaceuticals Private Limited | Director |
| Shailendra Kumar Dwivedi | 08680173 | Segmed Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pawan Kumar Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pawan Kumar Singh
Pawan Kumar Singh currently holds 1 directorship: Segmed Pharmaceuticals Private Limited (Director, since 27 Jan 2020, revenue ₹5.4 Lakh (FY 2024)).
Pawan Kumar Singh was first appointed on 27 Jan 2020 as Director at Segmed Pharmaceuticals Private Limited.
The current boards of Pawan Kumar Singh's companies include Neeraj Srivastava (Segmed Pharmaceuticals Private Limited), Shailendra Kumar Dwivedi (Segmed Pharmaceuticals Private Limited).